Josh Merkel has over 10 years of experience in the biotech/pharma industry supporting various technical roles as a subject matter expert and people manager. Prior to joining AmplifyBio, Josh was at Instil Bio as the head of Site MSAT, establishing the foundations for US clinical manufacturing of autologous solid-tumor cell therapy. Previous roles include time at Kite Pharma, also supporting as MSAT in cell therapy for clinical and commercial CAR-T autologous product, and at Baxter Healthcare supporting commercial blood plasma fractionation and purification as a compliance technical writer and process sciences engineer. Josh received his B.S. in Bioengineering from University of California, Los Angeles.